Create Account | Sign In: Author or Forum

Search Symptoms


RSNA: Corticosteroid Injections Appear to Worsen Knee Osteoarthritis

November 30, 2022. 4:34 PM CST.

Corticosteroids linked to progression of knee OA based on whole-organ magnetic resonance imaging scores, KL grade

By Elana Gotkine HealthDay Reporter Read article


ACR: Long-Term Safety Demonstrated for Anifrolumab in Lupus

November 21, 2022

Exposure-adjusted incidence rates of serious adverse events 8.5 versus 11.2 per 100 patient-years for anifrolumab versus placebo

ACR: Holding Methotrexate for Just a Week After Flu Vaccine Works for RA Patients

November 18, 2022

Authors say immune response similar for patients holding methotrexate for one week or two weeks

ACR: Low-Dose Hydroxychloroquine Tied to More Hospitalizations for Lupus Flares

November 18, 2022

Both weight-based and non-weight-based low-dose HCQ associated with increased hospitalizations for SLE

ACAAI: Epinephrine Auto-Injector Use Low Among Adults With Food Allergy

November 14, 2022

Furthermore, one-third of adults with food allergy think epinephrine auto-injectors can cause life-threatening effects

AHA: Other Defibrillation Strategies Studied for Refractory V-Fib

November 09, 2022

Survival to hospital discharge higher with use of double sequential external defibrillation compared with standard defibrillation

ASN: Empagliflozin Cuts Risk for Progression in CKD

November 09, 2022

Risk for progression of kidney disease or death from cardiovascular causes reduced with empagliflozin versus placebo

ASN: Discontinuation of RAS Inhibitors Does Not Increase eGFR in CKD

November 09, 2022

No difference seen with discontinuation, continuation of RAS inhibitors among patients with advanced, progressive chronic kidney disease

AHA: Strategies Compared for Treating Chronic Limb-Threatening Ischemia

November 08, 2022

Outcomes better for surgical revascularization versus endovascular therapy for those with single segment of great saphenous vein that could be used for surgery

AHA: Baxdrostat Studied in Treatment-Resistant Hypertension

November 08, 2022

Dose-dependent reductions in systolic blood pressure seen in phase 2 dose-ranging study

AHA: Lowering TGs With Pemafibrate Does Not Cut CV Risk in T2DM

November 08, 2022

In patients with T2DM, hypertriglyceridemia, and low HDL cholesterol levels, the risk for cardiovascular events was not lower with pemafibrate versus placebo

AHA: Environmental Exposures Tied to CVD Deaths in the U.S., U.K.

November 07, 2022

Risk-attributable cardiovascular death rate associated with lead exposure higher in the U.S. than the U.K.; opposite pattern seen between the countries for particulate matter exposure

AHA: Vaping Tied to Negative Effects on Cardiovascular Function

November 07, 2022

Increases in BP, heart rate greater; reduction in brachial artery diameter greater; and performance on exercise parameters worse for vapers, smokers compared with controls

AHA: Those With, at Risk for CVD Less Likely to Use Wearables

November 04, 2022

Wearable health device use in the U.S. lower among those older than 65 years, higher among those with higher household income, educational attainment

AHA: Heart Disease Death Rates in U.S. Spiked in 2020

November 04, 2022

Following steady decline from 2010 to 2019, death rates increased in 2020, especially among young adults, non-Hispanic Blacks

AHA: Once-Daily Edoxaban Seems Safe for Pediatric Cardiac Patients

November 04, 2022

Rates of clinically relevant bleeding similar between groups receiving edoxaban or standard-of-care anticoagulation